로그인|회원가입|고객센터|HBR Korea
페이지 맨 위로 이동
검색버튼 메뉴버튼

Medical / Clinical Case

Mother’s Liver, Stem Cell Transplant Saves Rare-Disease Child

Dong-A Ilbo | Updated 2026.01.26
On the 13th, Professor Kim Hye-ri (right) of the Division of Pediatric Hematology and Oncology at Asan Medical Center in Seoul examines 13-year-old Yoo Eun-seo, who successfully received a liver and hematopoietic stem cells from her mother and has been able to discontinue immunosuppressants. Provided by Asan Medical Center.

A 13-year-old patient suffering from liver cirrhosis due to a rare, intractable disease has regained a healthy daily life after sequential transplants of her mother’s liver and hematopoietic stem cells.

On the 26th, Asan Medical Center in Seoul announced that it had successfully induced “immune tolerance” in 13-year-old patient Yoo Eun-seo, who has the rare intractable disease hypereosinophilic syndrome, by sequentially transplanting her mother’s liver and haploidentical hematopoietic stem cells. As a result, liver function and hematopoietic function are being maintained normally even after complete discontinuation of immunosuppressants.

Hypereosinophilic syndrome is a disease in which eosinophils, a type of white blood cell, proliferate abnormally due to a bone marrow disorder and attack major organs. Yoo was diagnosed with this disease in 2017 and has since undergone treatment, including a colostomy. In 2023, she developed liver failure complications such as esophageal variceal bleeding, and in 2024 she experienced ascites, a condition in which fluid accumulates in the abdomen. In August of the same year, she received a liver transplant from her mother. To treat the underlying cause of the disease, the bone marrow disorder, the medical team also transplanted her mother’s hematopoietic stem cells in February 2025.

In general, organ transplant recipients must take immunosuppressants for life to prevent immune cells from recognizing the transplanted organ as a foreign invader and attacking it. In Yoo’s case, however, hematopoietic stem cells from the same donor established a new immune system that recognizes the already transplanted maternal liver not as an external organ but as its own. Asan Medical Center in Seoul explained, “This is the first case in Korea in which immune tolerance has been induced through sequential transplantation in a pediatric patient with hypereosinophilic syndrome.”

After the hematopoietic stem cell transplant, it was confirmed that 100% of Yoo’s blood cells had been replaced by her mother’s cells and that no further abnormal eosinophils were being produced.

Yoo’s mother, Ms. Park, said, “My heart ached when Eun-seo could not freely enjoy snacks with her friends because she had to take immunosuppressants,” adding, “It feels like a dream that she can now run around and eat whatever she wants without medication.”

Bang Sung-eun

AI-translated with ChatGPT. Provided as is; original Korean text prevails.
Popular News

경영·경제 질문은 AI 비서에게,
무엇이든 물어보세요.

Click!